Microbix Biosystems Inc. (TSX:MBX)
Canada · Delayed Price · Currency is CAD 0.3000
+0.0100 (3.45%)
Oct 30, 2026, 3:59 PM EDT
Microbix Biosystems Market Cap
Microbix Biosystems has a market cap or net worth of CAD 41.09 million as of October 30, 2026. It is the 33,955th most valuable company in the world and the 998th biggest in Canada. Its market cap has increased by 20.22% in one year.
Market Cap
41.09M
Enterprise Value
40.65M
Revenue
15.40M
Global Rank
Country Rank
#998 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since October 1, 1992, Microbix Biosystems's market cap has increased from 13.38M to 41.09M, an increase of 207.06%. That is a compound annual growth rate of 3.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 41.09M | 28.54% |
| Dec 31, 2025 | 31.97M | -41.99% |
| Dec 31, 2024 | 55.10M | 3.47% |
| Dec 29, 2023 | 53.25M | -6.55% |
| Dec 30, 2022 | 56.99M | -47.62% |
| Dec 31, 2021 | 108.80M | 135.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 48.20M |
| Thiogenesis Therapeutics | 44.79M |
| Medicenna Therapeutics | 44.30M |
| Sharp Therapeutics | 43.26M |
| Sernova Biotherapeutics | 41.54M |
| BriaCell Therapeutics | 40.45M |
| MedMira | 35.09M |
| Sona Nanotech | 34.38M |